Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results (Q34001872)

30 July 2017

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results (English)

1 reference

30 July 2017

0 references

Kenneth J Rothman

7

0 references

Til Stürmer

series ordinal

3

object named as

Til Stürmer

1 reference

30 July 2017

4

M Alan Brookhart

1 reference

PubMed ID

17909372

30 July 2017

Sebastian Schneeweiss

series ordinal

1

object named as

Sebastian Schneeweiss

1 reference

30 July 2017

8

Robert J Glynn

1 reference

30 July 2017

5

Jerry Avorn

1 reference

30 July 2017

6

Malcolm Maclure

1 reference

30 July 2017

Amanda R Patrick

2

1 reference

PubMed ID

17909372

30 July 2017

language of work or name

1 reference

1 October 2007

1 reference

30 July 2017

1 reference

30 July 2017

45

1 reference

30 July 2017

10 Supl 2

1 reference

30 July 2017

S131-42

1 reference

Insights into different results from different causal contrasts in the presence of effect-measure modification.

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

A review of uses of health care utilization databases for epidemiologic research on therapeutics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Causation of bias: the episcope

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

The treatment of unrelated disorders in patients with chronic medical diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Run-in periods in randomized trials: implications for the application of results in clinical practice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Estimating causal effects from large data sets using propensity scores

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Why we need observational studies to evaluate the effectiveness of health care

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Channeling bias in the interpretation of drug effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

The exclusion of the elderly and women from clinical trials in acute myocardial infarction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Paradoxical relations of drug treatment with mortality in older persons.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

29 October 2018

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus

1 reference

12 December 2020

Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation

1 reference

12 December 2020

Selective prescribing led to overestimation of the benefits of lipid-lowering drugs

1 reference

12 December 2020

An analysis of the exclusion criteria used in observational pharmacoepidemiological studies

1 reference

12 December 2020

10.1097/MLR.0B013E318070C08E

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

PubMed ID

17909372